Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MiMedx Group (MDXG)
NASDAQ:MDXG
MDXG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.47 - $10.14
Previous CloseN/A
Volume99.42K
Average Volume (3M)573.26K
Market Cap
$1.21B
Enterprise Value$807.11M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13.8
Beta0.82
Next Earnings
Feb 26, 2025EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.58
Shares Outstanding146,946,210
10 Day Avg. Volume460,980
30 Day Avg. Volume573,262
Standard Deviation0.20
R-Squared0.26
Alpha0.00093
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.52
Price to Cash Flow (P/CF)15.40
P/FCF Ratio15.50
Enterprise Value/Market Cap0.67
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.02
Enterprise Value/Ebitda12.24
Forecast
1Y Price Target
$13.00Price Target Upside61.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
MiMedx Group News
PremiumCompany Announcements
MiMedx Group Inc. Reports Q3 2024 Financial Results
PremiumCompany Announcements
MiMedx Group Reports 3% Sales Increase in Q3 2024
---
Bulls Say, Bears Say
Bulls Say
Market ShareMiMedx Group's status as a good actor with strong products on approved Skin Substitute lists is expected to drive market share growth.
Regulatory EnvironmentThe finalized Skin Substitute rules are favorable for good actors like MiMedx Group, potentially increasing the adoption of their products.
Bears Say
Reimbursement PoliciesContinuing reimbursement uncertainty disrupted the business in the physician office setting.
---
Ownership Overview
1.68% Insiders
10.11% Mutual Funds
34.82% Other Institutional Investors
43.58% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDXG FAQ
What was MiMedx Group’s price range in the past 12 months?
MiMedx Group lowest stock price was $5.47 and its highest was $10.14 in the past 12 months.
What is MiMedx Group’s market cap?
MiMedx Group’s market cap is $1.21B.
When is MiMedx Group’s upcoming earnings report date?
MiMedx Group’s upcoming earnings report date is Feb 26, 2025 which is in 5 days.
How were MiMedx Group’s earnings last quarter?
MiMedx Group released its earnings results on Oct 30, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.044 by $0.006.
Is MiMedx Group overvalued?
According to Wall Street analysts MiMedx Group’s price is currently Undervalued.
Does MiMedx Group pay dividends?
MiMedx Group does not currently pay dividends.
What is MiMedx Group’s EPS estimate?
MiMedx Group’s EPS estimate is 0.07.
How many shares outstanding does MiMedx Group have?
MiMedx Group has 146,946,210 shares outstanding.
What happened to MiMedx Group’s price movement after its last earnings report?
MiMedx Group reported an EPS of $0.05 in its last earnings report, beating expectations of $0.044. Following the earnings report the stock price went up 20.387%.
Which hedge fund is a major shareholder of MiMedx Group?
Currently, no hedge funds are holding shares in MDXG
---
MiMedx Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (61.29% Upside)
$13.00 (61.29% Upside)
Blogger Sentiment
Bullish
MDXG Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 19.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.1%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
62.47%
Trailing 12-Months
Asset Growth
29.03%
Trailing 12-Months
Company Description
MiMedx Group
MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.
---
MDXG Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While the company achieved revenue growth, maintained strong cash flow, and saw positive developments with new products like HELIOGEN, it faced significant challenges from reimbursement issues and declines in surgical sales. The sentiment is cautiously optimistic with expectations for future growth.Read More>---
MDXG Stock 12 Month Forecast
Average Price Target
$13.00
▲(61.29% Upside)
Technical Analysis
Apyx Medical
―
Orasure Technologies
―
T2 Biosystems
―
Iterum Therapeutics
―
Journey Medical Corp
―
Best Analysts Covering MDXG
1 Year
1 Year Success Rate
11/12 ratings generated profit
1 Year Average Return
+60.34%
reiterated a buy rating 10 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +60.34% per trade.
---